- Early StageStartup in initial stages
EmGenisys careers
EmGenisys aims to improve animal production and promote sustainability through advancements in assisted reproductive technologies (ARTs). With this mission we created the world’s most comprehensive embryo evaluation system to improve pregnancy outcomes of ARTs in livestock.
Our technology utilizes video motion magnification to enable embryo growth and development to be humanly perceptible in real time. To use the system, the veterinarian records a 30 second video of embryos in culture with standard video equipment. The videos can then be sent to “the cloud” in which EmGenisys proprietary software filters the videos and performs an analysis on the embryos cellular activity. Embryos are objectively ranked so the ET practitioner can select to transfer the healthiest embryos into recipient with the highest likelihood to survive to term. EmGenisys technology surpasses the industry gold standard for embryo assessment and requires a fraction of the time and cost.
Our technology utilizes video motion magnification to enable embryo growth and development to be humanly perceptible in real time. To use the system, the veterinarian records a 30 second video of embryos in culture with standard video equipment. The videos can then be sent to “the cloud” in which EmGenisys proprietary software filters the videos and performs an analysis on the embryos cellular activity. Embryos are objectively ranked so the ET practitioner can select to transfer the healthiest embryos into recipient with the highest likelihood to survive to term. EmGenisys technology surpasses the industry gold standard for embryo assessment and requires a fraction of the time and cost.
EmGenisys hasn't added any jobs yet
Get notified when EmGenisys posts new jobs.
Cara Wells
Founder @EmGenisys PhD in Animal Sciecne
Valuation
$0
Funded over
1 round
Latest round
Pre-Seed (Jan 2022)
Glaxosmithkline • Seattle • $158k – $264k • 1 week ago
Noble Biomaterials • Scranton • $64k – $84k • 2 weeks ago
Penumbra • Roseville • $126k – $180k • 3 weeks ago
Syndax Pharmaceuticals • New York City • 3 weeks ago
Akebia Therapeutics • Oakland • $178k – $220k • 3 weeks ago




